Literature DB >> 21057815

Pandemic H1N1 influenza A infection and (atypical) HUS--more than just another trigger?

Upton Allen1, Christoph Licht.   

Abstract

Atypical hemolytic uremic syndrome (aHUS) is caused by mutations resulting in an exceedingly active alternative complement pathway. While today more than half a dozen genes are involved in aHUS pathology, only about 50% of carriers precipitate the disease. The reason for this phenomenon remains unclear, and triggering events like intercurrent infections have been postulated. In this context, reports on the development of (a)HUS in patients concomitantly diagnosed with pandemic H1N1 influenza A (pH1N1) infection are of great interest. They establish--for the first time in the literature--the link between aHUS and pH1N1 infection. While illnesses associated with pH1N1 infections during the recent pandemics were generally mild, secondary bacterial infections (e.g. Streptococcus pneumoniae) are known in patients with influenza A infections to not only aggravate the disease course, but also serve as a possible HUS trigger. Assuming pH1N1 was the cause of HUS in the cases reported here, it remains an interesting but unanswered hypothesis whether an underlying complement defect served as a susceptibility factor, at least in a subgroup of patients. In the future, pH1N1, but also pH1N1-associated, bacterial infections will have to be considered in (a)HUS patients, and further studies will be required to examine the role of the complement system in this condition.

Entities:  

Mesh:

Year:  2010        PMID: 21057815     DOI: 10.1007/s00467-010-1690-z

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  15 in total

1.  [Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia].

Authors:  C GASSER; E GAUTIER; A STECK; R E SIEBENMANN; R OECHSLIN
Journal:  Schweiz Med Wochenschr       Date:  1955-09-20

2.  Pandemic influenza A (H1N1) 2009-associated hemolytic uremic syndrome.

Authors:  Nikoleta Printza; Emmanouel Roilides; Maria Kotsiou; Dimitrios Zafeiriou; Venizelos Hatzidimitriou; Fotios Papachristou
Journal:  Pediatr Nephrol       Date:  2010-07-14       Impact factor: 3.714

3.  Hemolytic uremic syndrome triggered with a new pandemic virus: influenza A (H1N1).

Authors:  Aysun Caltik; Sare Gülfem Akyüz; Ozlem Erdogan; Gülay Demircin
Journal:  Pediatr Nephrol       Date:  2010-09-28       Impact factor: 3.714

Review 4.  Atypical hemolytic-uremic syndrome.

Authors:  Marina Noris; Giuseppe Remuzzi
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

5.  Novel findings from the second wave of adult pH1N1 in the United States.

Authors:  Lewis Satterwhite; Ashish Mehta; Greg S Martin
Journal:  Crit Care Med       Date:  2010-10       Impact factor: 7.598

Review 6.  A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders.

Authors:  N Besbas; D Karpman; D Landau; C Loirat; W Proesmans; G Remuzzi; G Rizzoni; C M Taylor; N Van de Kar; L B Zimmerhackl
Journal:  Kidney Int       Date:  2006-06-14       Impact factor: 10.612

Review 7.  Insights into the interaction between influenza virus and pneumococcus.

Authors:  Jonathan A McCullers
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

8.  Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, March-April 2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-05-08       Impact factor: 17.586

9.  Non-enteropathic hemolytic uremic syndrome: causes and short-term course.

Authors:  Alex R Constantinescu; Martin Bitzan; Lynne S Weiss; Erica Christen; Bernard S Kaplan; Avital Cnaan; Howard Trachtman
Journal:  Am J Kidney Dis       Date:  2004-06       Impact factor: 8.860

10.  Reassortment patterns in Swine influenza viruses.

Authors:  Hossein Khiabanian; Vladimir Trifonov; Raul Rabadan
Journal:  PLoS One       Date:  2009-10-07       Impact factor: 3.240

View more
  14 in total

1.  [Vitrectomy for retinal proliferation in childhood following hemolytic uremic syndrome].

Authors:  G Wirths; M Alnawaiseh; N Eter
Journal:  Ophthalmologe       Date:  2016-07       Impact factor: 1.059

2.  Hemolytic uremic syndrome complicating Mycoplasma pneumoniae infection.

Authors:  Astrid Godron; Sabine Pereyre; Catherine Monet; Brigitte Llanas; Jérôme Harambat
Journal:  Pediatr Nephrol       Date:  2013-06-26       Impact factor: 3.714

3.  Clinical guides for atypical hemolytic uremic syndrome in Japan.

Authors:  Hideki Kato; Masaomi Nangaku; Hiroshi Hataya; Toshihiro Sawai; Akira Ashida; Rika Fujimaru; Yoshihiko Hidaka; Shinya Kaname; Shoichi Maruyama; Takashi Yasuda; Yoko Yoshida; Shuichi Ito; Motoshi Hattori; Yoshitaka Miyakawa; Yoshihiro Fujimura; Hirokazu Okada; Shoji Kagami
Journal:  Clin Exp Nephrol       Date:  2016-08       Impact factor: 2.801

Review 4.  Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations.

Authors:  Maurizio Salvadori; Elisabetta Bertoni
Journal:  World J Nephrol       Date:  2013-08-06

5.  Occurrence of atypical HUS associated with influenza B.

Authors:  Karen van Hoeve; Corinne Vandermeulen; Marc Van Ranst; Elena Levtchenko; Lambert van den Heuvel; Djalila Mekahli
Journal:  Eur J Pediatr       Date:  2017-01-21       Impact factor: 3.183

Review 6.  Hemolytic uremic syndrome.

Authors:  Caterina Mele; Giuseppe Remuzzi; Marina Noris
Journal:  Semin Immunopathol       Date:  2014-02-14       Impact factor: 9.623

Review 7.  HUS and atypical HUS.

Authors:  T Sakari Jokiranta
Journal:  Blood       Date:  2017-04-17       Impact factor: 25.476

Review 8.  Atypical hemolytic uremic syndrome.

Authors:  Chantal Loirat; Véronique Frémeaux-Bacchi
Journal:  Orphanet J Rare Dis       Date:  2011-09-08       Impact factor: 4.123

9.  Eculizumab in secondary atypical haemolytic uraemic syndrome.

Authors:  Teresa Cavero; Cristina Rabasco; Antía López; Elena Román; Ana Ávila; Ángel Sevillano; Ana Huerta; Jorge Rojas-Rivera; Carolina Fuentes; Miquel Blasco; Ana Jarque; Alba García; Santiago Mendizabal; Eva Gavela; Manuel Macía; Luis F Quintana; Ana María Romera; Josefa Borrego; Emi Arjona; Mario Espinosa; José Portolés; Carolina Gracia-Iguacel; Emilio González-Parra; Pedro Aljama; Enrique Morales; Mercedes Cao; Santiago Rodríguez de Córdoba; Manuel Praga
Journal:  Nephrol Dial Transplant       Date:  2017-03-01       Impact factor: 5.992

Review 10.  Influenza-associated thrombotic microangiopathies.

Authors:  Martin Bitzan; Jakub Zieg
Journal:  Pediatr Nephrol       Date:  2017-09-07       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.